COVID-19 frequency and clinical course in children with asthma

Table 1 Evaluation of clinical features in different groups of asthma patients

	Others1 (n = 169)	Vaccinated patients (n = 57)	Atopic patients (n = 64)	P value	ES
Gender (male)	128/169 (47.6)	26/57 (45.6)	38/64 (59.4)	0.199	0.091
Fever	100/163 (61.3)	27/57 (47.4)	40/63 (63.5)	0.130	0.120
Fatigue	60/163 (36.8)	27/57 (47.4)	24/63 (38.1)	0.365	0.084
Headache	51/163 (31.3)	23/57 (40.4)	22/63 (34.9)	0.453	0.075
Muscle pain	62/163 (38)	17/57 (29.8)	18/63 (28.6)	0.296	0.093
Cough	53/163 (32.5)	24/57 (42.1)	17/63 (27)	0.205	0.106
Sore throat	41/163 (25.2)	15/57 (26.3)	10/63 (15.9)	0.280	0.095
Joint pain	43/163 (26.4)	11/57 (19.3)	13/63 (20.6)	0.452	0.075
Shortness of breath	23/163 (14.1)	17/57 (29.8)	14/63 (22.2)	0.026	0.160
Runny nose	19/163 (11.7)	5/57 (8.8)	5/63 (7.9)	0.653	0.055
Nausea	15/163 (9.2)	5/57 (8.8)	6/63 (9.5)	0.990	0.008
Vomiting	10/163 (6.1)	4/57 (7)	6/63 (9.5)	0.660	0.053
Diarrhea	9/163 (5.5)	4/57 (7)	2/63 (3.2)	0.624	0.057
Loss of taste and smell	6/163 (3.7)	6/57 (10.5)	3/63 (4.8)	0.148	0.119
Intra-familial contamination	59/164 (36)	15/57 (26.3)	31/64 (48.4)	0.039	0.151

¹This column includes asthma patients who are neither atopic nor vaccinated.

Statistics were shown as n/total n (%). ES: Effect size (Cramer v coefficient).